Jesse M Pines1, Mark S Zocchi2, Bernard S Black3, Jestin N Carlson4, Pablo Celedon5, Ali Moghtaderi6, Arvind Venkat7. 1. US Acute Care Solutions, Canton, OH, United States of America; Department of Emergency Medicine, Allegheny Health Network, Pittsburgh, PA, United States of America. Electronic address: pinesj@usacs.com. 2. The Heller School for Social Policy and Management, Brandeis University, Waltham, MA, United States of America. 3. Northwestern University, Pritzker School of Law and Kellogg School of Management, Evanston, IL, United States of America. 4. US Acute Care Solutions, Canton, OH, United States of America; Department of Emergency Medicine, Allegheny Health Network, Erie, PA, United States of America. 5. US Acute Care Solutions, Canton, OH, United States of America. 6. Milken Institute School of Public Health, George Washington University, Washington, DC, United States of America. 7. US Acute Care Solutions, Canton, OH, United States of America; Department of Emergency Medicine, Allegheny Health Network, Pittsburgh, PA, United States of America.
Abstract
OBJECTIVE: Higher opioid overdoses and drug use have reportedly occurred during the COVID-19 pandemic. We provide evidence on how emergency department (ED) visits for substance use disorders (SUD) changed in the early pandemic period. METHODS: Using retrospective data from January-July 2020 compared to January-July 2019, we calculated weekly 2020/2019 visit ratios for opioid-related, alcohol-related, other drug-related disorders, and all non-COVID-19 visits. We assess how this ratio as well as overall visit numbers changed after the mid-March 2020 onset of general pandemic restrictions. RESULTS: In 4.5 million ED visits in 2020 and 2019 to 108 EDs in 18 U.S. states, SUD visits were higher in early 2020 compared to 2019. During the peak-pandemic restriction period (March 13-July 31), non-COVID-19, non-SUD visits fell by approximately 45% early on, and then partly recovered with an average decline of 33% relative to 2019 levels. Visits for opioid-related, alcohol-related, and other drug-related disorders also declined, although less sharply, with an average drop of 17%, which was similar across SUD types. The visit ratios for 2020/2019 partially or fully recovered later in our sample period, depending on SUD type, but did not exceed early-2020 levels. However, substantial variation occurred across SUD types and across states. SUD visit declines were most prominent in the 65+ age group, except for alcohol-related visits where trends were similar across ages. SUD visits arriving by ambulance declined less or increased relative to self-transport visits, and ED deaths were rare. CONCLUSIONS: The 2020/2019 ratios of SUD ED visits fell substantially early in the COVID-19 pandemic, yet less than non-SUD, non-COVID ED visits. SUD ED visit ratios partly or fully recovered to 2019 levels by early June 2020, but did not exceed early 2020 ratios.
OBJECTIVE: Higher opioid overdoses and drug use have reportedly occurred during the COVID-19 pandemic. We provide evidence on how emergency department (ED) visits for substance use disorders (SUD) changed in the early pandemic period. METHODS: Using retrospective data from January-July 2020 compared to January-July 2019, we calculated weekly 2020/2019 visit ratios for opioid-related, alcohol-related, other drug-related disorders, and all non-COVID-19 visits. We assess how this ratio as well as overall visit numbers changed after the mid-March 2020 onset of general pandemic restrictions. RESULTS: In 4.5 million ED visits in 2020 and 2019 to 108 EDs in 18 U.S. states, SUD visits were higher in early 2020 compared to 2019. During the peak-pandemic restriction period (March 13-July 31), non-COVID-19, non-SUD visits fell by approximately 45% early on, and then partly recovered with an average decline of 33% relative to 2019 levels. Visits for opioid-related, alcohol-related, and other drug-related disorders also declined, although less sharply, with an average drop of 17%, which was similar across SUD types. The visit ratios for 2020/2019 partially or fully recovered later in our sample period, depending on SUD type, but did not exceed early-2020 levels. However, substantial variation occurred across SUD types and across states. SUD visit declines were most prominent in the 65+ age group, except for alcohol-related visits where trends were similar across ages. SUD visits arriving by ambulance declined less or increased relative to self-transport visits, and ED deaths were rare. CONCLUSIONS: The 2020/2019 ratios of SUD ED visits fell substantially early in the COVID-19 pandemic, yet less than non-SUD, non-COVID ED visits. SUD ED visit ratios partly or fully recovered to 2019 levels by early June 2020, but did not exceed early 2020 ratios.
Authors: Jestin N Carlson; Krista M Foster; Jesse M Pines; Christopher K Corbit; Michael J Ward; Muhammad Zia Hydari; Arvind Venkat Journal: Ann Emerg Med Date: 2017-07-26 Impact factor: 5.721
Authors: Jacob J Wainwright; Meriam Mikre; Penn Whitley; Eric Dawson; Angela Huskey; Andrew Lukowiak; Brett P Giroir Journal: JAMA Date: 2020-10-27 Impact factor: 56.272
Authors: Kristin M Holland; Christopher Jones; Alana M Vivolo-Kantor; Nimi Idaikkadar; Marissa Zwald; Brooke Hoots; Ellen Yard; Ashley D'Inverno; Elizabeth Swedo; May S Chen; Emiko Petrosky; Amy Board; Pedro Martinez; Deborah M Stone; Royal Law; Michael A Coletta; Jennifer Adjemian; Craig Thomas; Richard W Puddy; Georgina Peacock; Nicole F Dowling; Debra Houry Journal: JAMA Psychiatry Date: 2021-04-01 Impact factor: 21.596
Authors: Kathleen P Hartnett; Aaron Kite-Powell; Jourdan DeVies; Michael A Coletta; Tegan K Boehmer; Jennifer Adjemian; Adi V Gundlapalli Journal: MMWR Morb Mortal Wkly Rep Date: 2020-06-12 Impact factor: 17.586
Authors: Svetla Slavova; Peter Rock; Heather M Bush; Dana Quesinberry; Sharon L Walsh Journal: Drug Alcohol Depend Date: 2020-07-10 Impact factor: 4.492
Authors: Molly M Jeffery; Gail D'Onofrio; Hyung Paek; Timothy F Platts-Mills; William E Soares; Jason A Hoppe; Nicholas Genes; Bidisha Nath; Edward R Melnick Journal: JAMA Intern Med Date: 2020-10-01 Impact factor: 21.873
Authors: Gabriel Vallecillo; Francina Fonseca; Lina Oviedo; Xavier Durán; Ignacio Martinez; Alexandra García-Guix; Claudio Castillo; Marta Torrens; Santiago Llana; Albert Roquer; Maria de la Cabeza Martinez; Sandra Aguelo; Irene Canosa Journal: Drug Alcohol Depend Rep Date: 2022-01-15
Authors: Arjun K Venkatesh; Alexander T Janke; Jeremy Kinsman; Craig Rothenberg; Pawan Goyal; Caitlin Malicki; Gail D'Onofrio; Andrew Taylor; Kathryn Hawk Journal: PLoS One Date: 2022-01-13 Impact factor: 3.752
Authors: Michael Liu; Lucie Richard; Michael A Campitelli; Rosane Nisenbaum; Naheed Dosani; Irfan A Dhalla; Rishi K Wadhera; Salimah Z Shariff; Stephen W Hwang Journal: Addiction Date: 2022-02-14 Impact factor: 7.256
Authors: Anh Truc Vo; Thomas Patton; Amy Peacock; Sarah Larney; Annick Borquez Journal: Int J Environ Res Public Health Date: 2022-07-21 Impact factor: 4.614
Authors: Hania Rahimi-Ardabili; Xiaoqi Feng; Phi-Yen Nguyen; Thomas Astell-Burt Journal: Int J Environ Res Public Health Date: 2022-10-07 Impact factor: 4.614
Authors: Jesse M Pines; Mark S Zocchi; Bernard S Black; Rebecca Kornas; Pablo Celedon; Ali Moghtaderi; Arvind Venkat Journal: Ann Emerg Med Date: 2021-04-27 Impact factor: 5.721